RNA splicing modulator / Sanofi, Skyhawk Therap - LARVOL DELTA

Skyhawk Therapeutics to Present Preclinical Data on SKY-1214 at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium (PRNewswire) - "Skyhawk Therapeutics...announced the company will deliver a poster presentation highlighting preclinical data on SKY-1214 at the 36th European Organization for Research and Treatment of Cancer (EORTC)-National Cancer Institute (NCI)-American Association for Cancer Research (AACR) Molecular Targets and Cancer Therapeutics Symposium ('EORTC-NCI-AACR') to be held from October 23-25, 2024 in Barcelona, Spain."

Preclinical • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology